• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ARS Pharmaceuticals, Inc. - Common Stock (NQ:SPRY)

2.545 -0.105 (-3.96%)
Delayed Quote Updated: 9:35 AM EST, Nov 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 205,892
Open 2.660
Bid (Size) 2.530 (200)
Ask (Size) 2.560 (500)
Prev. Close 2.650
Today's Range 2.440 - 2.715
52wk Range 2.720 - 13.15
Shares Outstanding 95,568,307
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
ARS Pharma (SPRY) Q3 2026 Earnings Call Transcript ↗
Today 9:28 EST
Prior authorizations are the biggest leak in neffy's prescription-to-fill funnel. 
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
ARS Pharmaceuticals Q3 Earnings Call Highlights ↗
November 05, 2026
Via MarketBeat
Topics Earnings

Performance

52-Week Range 80.6% below 52-week high
2.545
2.7252W Low 13.1552W High
1 Week 32.8% below 1-week high
2.721W Low 3.791W High

ARS Pharmaceuticals, Inc. - Common Stock (SPRY) traded between $2.72 and $13.15 over the past 52 weeks and last traded at $2.54, 80.6% below its 52-week high. Over the past week it ranged between $2.72 and $3.79.

Past 12 Months
-24.7%
-40.7%
-54.1%
-71.7%
-77.9%
-71.9%
1W -$0.83
1M -$1.75
3M -$3.00
6M -$6.46
YTD -$8.95
1Y -$6.51

SPRY was -71.9% over the past year, -71.7% over six months, -77.9% year to date, -24.7% in the last week.

12 Months vs Market
SPRY
-71.9%
DIA
+7.8%
SPY
+8.7%
QQQ
+5.4%
IWM
+10.7%

Over the past 12 months SPRY returned -71.9% versus DIA (Dow) +7.8%, SPY (S&P 500) +8.7%, QQQ (Nasdaq 100) +5.4% and IWM (Russell 2000) +10.7%.

Volume & Liquidity 0.12× 3-mo avg
Today 205,892 3-mo avg 1.7M
1W
2.1M
1M
1.7M
3M
1.7M
6M
1.8M
YTD
1.7M
1Y
1.8M

SPRY most recently traded 205,892 shares against a 3-month average daily volume of 1.7M.

More News

Read More
News headline image
ARS Pharma Reports Business Highlights and Third Quarter 2026 Financial Results
November 05, 2026
From ARS Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
ARS Pharma to Report Third Quarter 2026 Financial Results
October 28, 2026
From ARS Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
October 05, 2026
From Schall, Brown & Schwartz LLP
Via Business Wire
News headline image
SPRY FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
October 05, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
ARS PHARMACEUTICALS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 5 Deadline in Securities Class Action – SPRY
October 02, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
ARS PHARMACEUTICALS DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Reminds ARS Pharmaceuticals Investors to Contact the Firm Before October 5th Seeking Lead Plaintiff Role
October 02, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Kaplan Fox Encourages Investors of ARS Pharmaceuticals Inc. (NASDAQ: SPRY) to Contact the Firm Before Lead Plaintiff Deadline on October 5, 2026
October 02, 2026
Via NewMediaWire
Topics Lawsuit Retirement
News headline image
Kaplan Fox Reminds Investors of ARS Pharmaceuticals Inc. (NASDAQ: SPRY) to a Securities Class Action Deadline - Contact the Firm Before October 5, 2026
September 30, 2026
Via NewMediaWire
Topics Lawsuit Retirement
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – SPRY
September 29, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
ARS PHARMACEUTICALS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 5 Deadline in Securities Class Action – SPRY
September 28, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
September 28, 2026
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
Kaplan Fox Encourages Investors of ARS Pharmaceuticals Inc. (NASDAQ: SPRY) to Contact the Firm to Learn About Their Legal Rights
September 28, 2026
Via NewMediaWire
Topics Lawsuit Retirement
News headline image
SPRY INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
September 26, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Kaplan Fox Encourages ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors to Contact the Firm Before the Deadline on October 5, 2026
September 25, 2026
Via NewMediaWire
Topics Lawsuit Retirement
News headline image
Kaplan Fox Alerts ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors Who Suffered Losses to a Securities Class Action – Deadline is October 5, 2026
September 25, 2026
From Kaplan Fox & Kilsheimer, LLP
Via GlobeNewswire
News headline image
Kaplan Fox Encourages Investors of ARS Pharmaceuticals Inc. (NASDAQ: SPRY) to Contact the Firm Before Lead Plaintiff Deadline on October 5, 2026
September 24, 2026
Via NewMediaWire
Topics Lawsuit Retirement
News headline image
Bragar Eagel & Squire, P.C. Reminds ARS Pharmaceuticals Investors to Contact the Firm Before October 5th Seeking Lead Plaintiff Role
September 24, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
September 24, 2026
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
Kaplan Fox Encourages Investors of ARS Pharmaceuticals Inc. (NASDAQ: SPRY) to Contact the Firm to Learn About Their Legal Rights
September 24, 2026
Via NewMediaWire
Topics Lawsuit Retirement
News headline image
Kaplan Fox Alerts Investors to an Upcoming Deadline of October 5, 2026 in the ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Securities Class Action
September 23, 2026
Via NewMediaWire
Topics Lawsuit Retirement
News headline image
Kaplan Fox Reminds ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors with Significant Losses to Seek a Leadership Role Before Deadline on October 5, 2026
September 23, 2026
From Kaplan Fox & Kilsheimer, LLP
Via GlobeNewswire
News headline image
Kaplan Fox Alerts ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors to Seek Leadership in a Securities Fraud Lawsuit by October 5, 2026
September 22, 2026
Via NewMediaWire
Topics Fraud Lawsuit Retirement
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – SPRY
September 22, 2026
From Pomerantz LLP
Via GlobeNewswire

Frequently Asked Questions

Is ARS Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, ARS Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does ARS Pharmaceuticals, Inc. - Common Stock trade on?
ARS Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ARS Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for ARS Pharmaceuticals, Inc. - Common Stock is SPRY on the Nasdaq Stock Market
What is the current price of ARS Pharmaceuticals, Inc. - Common Stock?
The current price of ARS Pharmaceuticals, Inc. - Common Stock is 2.545
When was ARS Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of ARS Pharmaceuticals, Inc. - Common Stock was at 11/06/26 09:35 AM ET
What is the market capitalization of ARS Pharmaceuticals, Inc. - Common Stock?
The market capitalization of ARS Pharmaceuticals, Inc. - Common Stock is 243.22M
How many shares of ARS Pharmaceuticals, Inc. - Common Stock are outstanding?
ARS Pharmaceuticals, Inc. - Common Stock has 243M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap